1Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, Beth Israel Deaconess Medical Center, Boston, MA. 2Center for Healthcare Delivery Science, Beth Israel Deaconess Medical Center, Boston, MA. 3Harvard Medical School, Boston, MA. 4Department of Medicine, Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA. 5Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Boston, MA. 6Section of Pulmonary and Critical Care, Department of Medicine, University of Chicago, Chicago, IL.
Crit Care Med. 2014 Mar;42(3):497-503. doi: 10.1097/CCM.0b013e3182a66903.
The Centers for Disease Control has recently proposed a major change in how ventilator-associated pneumonia is defined. This has profound implications for public reporting, reimbursement, and accountability measures for ICUs. We sought to provide evidence for or against this change by quantifying limitations of the national definition of ventilator-associated pneumonia that was in place until January 2013, particularly with regard to comparisons between, and ranking of, hospitals and ICUs.
A prospective survey of a nationally representative group of 43 hospitals, randomly selected from the American Hospital Association Guide (2009). Subjects classified six standardized vignettes of possible cases of ventilator-associated pneumonia as pneumonia or no pneumonia.
Individuals responsible for ventilator-associated pneumonia surveillance at 43 U.S. hospitals.
None.
We measured the proportion of standardized cases classified as ventilator-associated pneumonia. Of 138 hospitals consented, 61 partially completed the survey and 43 fully completed the survey (response rate 44% and 31%, respectively). Agreement among hospitals about classification of cases as ventilator-associated pneumonia/not ventilator-associated pneumonia was nearly random (Fleiss κ 0.13). Some hospitals rated 0% of cases as having pneumonia; others classified 100% as having pneumonia (median, 50%; interquartile range, 33-66%). Although region of the country did not predict case assignment, respondents who described their region as "rural" were more likely to judge a case to be pneumonia than respondents elsewhere (relative risk, 1.25, Kruskal-Wallis chi-square, p = 0.03).
In this nationally representative study of hospitals, assignment of ventilator-associated pneumonia is extremely variable, enough to render comparisons between hospitals worthless, even when standardized cases eliminate variability in clinical data abstraction. The magnitude of this variability highlights the limitations of using poorly performing surveillance definitions as methods of hospital evaluation and comparison, and our study provides very strong support for moving to a more objective definition of ventilator-associated complications.
疾病控制中心最近提出了一个重大改变,即呼吸机相关性肺炎的定义。这对 ICU 的公共报告、报销和问责措施有深远的影响。我们试图通过量化 2013 年 1 月之前使用的呼吸机相关性肺炎国家定义的局限性来提供支持或反对这一改变的证据,特别是在医院和 ICU 之间的比较和排名方面。
对来自美国医院协会指南(2009 年)的 43 家随机选择的具有全国代表性的医院进行前瞻性调查。研究对象将 6 个标准化的呼吸机相关性肺炎可能病例分类为肺炎或非肺炎。
来自 43 家美国医院的负责呼吸机相关性肺炎监测的个人。
无。
我们测量了将标准化病例分类为呼吸机相关性肺炎的比例。在同意的 138 家医院中,61 家部分完成了调查,43 家完全完成了调查(应答率分别为 44%和 31%)。医院对病例分类为呼吸机相关性肺炎/非呼吸机相关性肺炎的一致性几乎是随机的(Fleiss κ 0.13)。一些医院将 0%的病例评为肺炎;其他医院则将 100%的病例评为肺炎(中位数为 50%;四分位间距为 33-66%)。虽然国家的地理位置并没有预测病例的归属,但描述其所在地区为“农村”的受访者比其他地区的受访者更有可能判断病例为肺炎(相对风险,1.25;Kruskal-Wallis χ²检验,p = 0.03)。
在这项具有全国代表性的医院研究中,呼吸机相关性肺炎的归属非常不一致,甚至在使用标准化病例消除临床数据提取的变异性时,医院之间的比较也毫无价值。这种变异性的程度突出了使用性能不佳的监测定义作为医院评估和比较方法的局限性,我们的研究为转向更客观的呼吸机相关性并发症定义提供了非常有力的支持。